Amrutanjan Health Care (NSE:AMRUTANJAN) Other Current Receivables: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AMRUTANJAN Amrutanjan Health Care Ltd NSE:AMRUTANJAN
71 GF Score
Price ₹490.95
GF Value ₹830.57
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Amrutanjan Health Care Other Current Receivables?

Amrutanjan Health Care NSE:AMRUTANJAN -0.47% 71 Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:AMRUTANJAN with a GF Score™ of 71/100 and a GF Value™ of ₹830.57 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Amrutanjan Health Care's Other Current Receivables for the quarter that ended in Jun. 2026 was ₹0 Mil.

Amrutanjan Health Care Other Current Receivables Related Terms

Amrutanjan Health Care Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Amrutanjan Health Care's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amrutanjan Health Care Other Current Receivables Chart

Amrutanjan Health Care Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Amrutanjan Health Care Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:AMRUTANJAN
71GF Score
Amrutanjan Health Care Ltd NSE:AMRUTANJAN
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amrutanjan Health Care Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹0 Mil mean?
Amrutanjan Health Care (NSE:AMRUTANJAN) has a Other Current Receivables of ₹0 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Amrutanjan Health Care and its competitors.
Is Amrutanjan Health Care's Other Current Receivables too high?
Amrutanjan Health Care's current Other Current Receivables is ₹0 Mil. Overall, Amrutanjan Health Care has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Amrutanjan Health Care's Other Current Receivables compare to ZTS?
Amrutanjan Health Care's Other Current Receivables of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Amrutanjan Health Care and its competitors. Amrutanjan Health Care's current Other Current Receivables is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amrutanjan Health Care stock overvalued right now?
Based on GuruFocus' analysis, Amrutanjan Health Care (NSE:AMRUTANJAN) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹830.57, compared to a current price of ₹490.95 — trading 40.9% below its estimated fair value. The current Other Current Receivables is ₹0 Mil. Amrutanjan Health Care's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Amrutanjan Health Care (NSE:AMRUTANJAN), the current Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Amrutanjan Health Care (NSE:AMRUTANJAN) Overvalued in 2026?

Based on GuruFocus' analysis, Amrutanjan Health Care stock appears to be undervalued. The current stock price of ₹490.95 is trading 40.9% below its estimated GF Value™ of ₹830.57. GuruFocus considers Amrutanjan Health Care to be Significantly Undervalued.

Key valuation signals for NSE:AMRUTANJAN:

  • Other Current Receivables: ₹0 Mil
  • GF Value™: ₹830.57 vs. price of ₹490.95 (40.9% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the NSE:AMRUTANJAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Amrutanjan Health Care Business Description

Other Exchanges 590006:India
Address No. 103 (Old No. 42-45), Luz Church Road, Mylapore, Chennai, TN, IND, 600 004
Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkins, and inhalers. Geographically, it generates the majority of the revenue from India.
71GF Score

Get the complete analysis for NSE:AMRUTANJAN

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹490.95
Price
₹830.57
GF Value